Supply Chain Archives
01/30/2025
Mapping the Future: Q&A with Mark Sawicki, Ph.D., on 2025 Trends in Cell and Gene Therapy
As the CGT industry enters a pivotal phase of commercial growth and therapy expansion, Cryoport Systems’ CEO, Mark Sawicki, Ph.D., shares his perspectives on where the market is headed.
12/16/2024
Solving Key Gene Therapy Logistics Challenges with Advanced Technology
Cryoport Systems developed the Cryoport Elite™ Ultra Cold shipping system with one mission in mind: to ensure that gene therapies reach their destination intact, uncompromised, and ready for patient treatment.
12/21/2023
Examining 2023 & 2024: Looking Back with President & CEO, Mark Sawicki
2023 was a year of highs and lows for the cell and gene therapy (CGT) market. The Alliance for Regenerative Medicine reported...
02/28/2023
